ClinicalTrials.Veeva

Menu

The Comparison of 32mm and 28mm Head Components in Alumina-alumina Total Hip Arthroplasty (THA)

Seoul National University logo

Seoul National University

Status and phase

Completed
Phase 4

Conditions

Arthroplasty, Replacement, Hip

Treatments

Device: 32mm ceramic head group
Device: 28mm ceramic head group

Study type

Interventional

Funder types

Other

Identifiers

NCT01098604
SNU 08-01

Details and patient eligibility

About

It has been postulated that use of a larger femoral head could reduce the risk of dislocation after total hip arthroplasty, but only limited clinical data have been presented in third generation alumina bearings.

The purpose of this study is to evaluate the effect of femoral head size for total hip arthroplasty using third generation alumina bearings on the joint stability and clinical results.

The investigators hypothesized that larger ceramic head group has a similar rate of dislocation and clinical results in smaller ceramic head group.

Enrollment

120 patients

Sex

All

Ages

20 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • osteonecrosis of femoral head
  • primary or secondary osteoarthritis of the hips
  • femoral neck fracture

Exclusion criteria

  • previous hemi- or total hip arthroplasty
  • highly dislocated or severe ankylosed hip
  • patients who are considered potentially unreliable or who may not reliably attend study visits

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

120 participants in 2 patient groups

32mm ceramic head group
Active Comparator group
Description:
patients performed with THA using 32mm ceramic head
Treatment:
Device: 32mm ceramic head group
28mm ceramic head group
Active Comparator group
Description:
patients performed with THA using 28mm ceramic head
Treatment:
Device: 28mm ceramic head group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems